Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-08-07

AUTHORS

Vipul Sheth, Myriam Labopin, Jonathan Canaani, Liisa Volin, Arne Brecht, Arnold Ganser, Jiri Mayer, Hélène Labussière-Wallet, Jörg Bittenbring, Roni Shouval, Bipin Savani, Mohammad Mohty, Arnon Nagler

ABSTRACT

FLAMSA followed by sequential reduced intensity conditioning and treosulfan/fludarabine are frequently used conditioning approaches used in centers of the European Society for Blood and Marrow Transplantation (EBMT) for older patients with acute myeloid leukemia (AML). It is currently unknown whether any of these regimens is superior to the others in terms of disease control and toxicity. Using the Acute Leukemia Working Party/EBMT multicenter registry we compared the outcomes of AML patients 45–65 of age transplanted between the years 2007 and 2016. A total of 629 patients were included in the analysis: 281 in the Treo/Flu group, 203 in the FLAMSA/TBI group, and 145 in the FLAMSA/Busulfan group. In multivariate analysis, FLAMSA/TBI conditioned patients had a decreased risk of relapse (hazard ratio (HR) = 0.43; 95% confidence interval (CI), 0.25–0.75; p = 0.002) and superior leukemia-free survival (HR = 0.67; 95% CI, 0.45–0.98; p = 0.042) compared to Treo/Flu conditioned patients. Rates of acute graft-versus-host disease (GVHD) were significantly higher in the FLAMSA/TBI group compared to the Treo/Flu group (HR = 2.004; 95% CI, 1.09–3.67; p = 0.024). Overall survival, non-relapse mortality, and chronic GVHD were not significantly impacted by the specific regimen used. The choice of either FLAMSA/TBI, FLAMSA/Bu, or Treo/Flu results in no major impact on survival of older AML patients. More... »

PAGES

531-539

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41409-018-0288-0

DOI

http://dx.doi.org/10.1038/s41409-018-0288-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1106016784

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30087463


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Busulfan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation Conditioning", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vidarabine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Stem Cell Transplant, Kings College Hospital, London, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.46699.34", 
          "name": [
            "Department of Hematology and Stem Cell Transplant, Kings College Hospital, London, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sheth", 
        "givenName": "Vipul", 
        "id": "sg:person.012411736330.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012411736330.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "EBMT Paris Office, CEREST-TC, Department of Hematology, Saint Antoine Hospital, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.412370.3", 
          "name": [
            "EBMT Paris Office, CEREST-TC, Department of Hematology, Saint Antoine Hospital, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Labopin", 
        "givenName": "Myriam", 
        "id": "sg:person.0762572112.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762572112.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel", 
          "id": "http://www.grid.ac/institutes/grid.12136.37", 
          "name": [
            "Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Canaani", 
        "givenName": "Jonathan", 
        "id": "sg:person.07616054555.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07616054555.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Stem Cell Transplantation Unit, HUCH Comprehensive Cancer Center, Helsinki, Finland", 
          "id": "http://www.grid.ac/institutes/grid.15485.3d", 
          "name": [
            "Stem Cell Transplantation Unit, HUCH Comprehensive Cancer Center, Helsinki, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Volin", 
        "givenName": "Liisa", 
        "id": "sg:person.07531174677.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07531174677.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Deutsche Klinik fuer diagnostik, KMT Zentrum, Weisbaden, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Deutsche Klinik fuer diagnostik, KMT Zentrum, Weisbaden, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brecht", 
        "givenName": "Arne", 
        "id": "sg:person.010617354074.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010617354074.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany", 
          "id": "http://www.grid.ac/institutes/grid.10423.34", 
          "name": [
            "Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ganser", 
        "givenName": "Arnold", 
        "id": "sg:person.01225227464.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225227464.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Hematooncology, University Hospital Brno, Brno, Czech Republic", 
          "id": "http://www.grid.ac/institutes/grid.412554.3", 
          "name": [
            "Department of Internal Medicine, Hematooncology, University Hospital Brno, Brno, Czech Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mayer", 
        "givenName": "Jiri", 
        "id": "sg:person.01045667334.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045667334.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center Hospitalier Lyon Sud, Pavillon Marcel B\u00e9rard -Bat 1G, Service Hematologie, Lyon, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Center Hospitalier Lyon Sud, Pavillon Marcel B\u00e9rard -Bat 1G, Service Hematologie, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Labussi\u00e8re-Wallet", 
        "givenName": "H\u00e9l\u00e8ne", 
        "id": "sg:person.01246454160.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246454160.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, BMT Unit, University of Saarland University Hospital, Homburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411937.9", 
          "name": [
            "Department of Internal Medicine, BMT Unit, University of Saarland University Hospital, Homburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bittenbring", 
        "givenName": "J\u00f6rg", 
        "id": "sg:person.01221434470.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221434470.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel", 
          "id": "http://www.grid.ac/institutes/grid.12136.37", 
          "name": [
            "Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shouval", 
        "givenName": "Roni", 
        "id": "sg:person.01270754501.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270754501.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Stem Cell Transplant, Vanderbilt University, Nashville, TN, USA", 
          "id": "http://www.grid.ac/institutes/grid.152326.1", 
          "name": [
            "Department of Hematology and Stem Cell Transplant, Vanderbilt University, Nashville, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Savani", 
        "givenName": "Bipin", 
        "id": "sg:person.01315375311.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315375311.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "EBMT Paris Office, CEREST-TC, Department of Hematology, Saint Antoine Hospital, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.412370.3", 
          "name": [
            "EBMT Paris Office, CEREST-TC, Department of Hematology, Saint Antoine Hospital, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mohty", 
        "givenName": "Mohammad", 
        "id": "sg:person.0644135047.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644135047.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel", 
          "id": "http://www.grid.ac/institutes/grid.12136.37", 
          "name": [
            "EBMT Paris Office, CEREST-TC, Department of Hematology, Saint Antoine Hospital, Paris, France", 
            "Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagler", 
        "givenName": "Arnon", 
        "id": "sg:person.0644252102.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644252102.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.leu.2404037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042454383", 
          "https://doi.org/10.1038/sj.leu.2404037"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2012.4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037876400", 
          "https://doi.org/10.1038/bmt.2012.4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1705259", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013673798", 
          "https://doi.org/10.1038/sj.bmt.1705259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1701899", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053658735", 
          "https://doi.org/10.1038/sj.bmt.1701899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-016-2887-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007456209", 
          "https://doi.org/10.1007/s00277-016-2887-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2015.305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022710270", 
          "https://doi.org/10.1038/bmt.2015.305"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2011.242", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023661469", 
          "https://doi.org/10.1038/bmt.2011.242"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-08-07", 
    "datePublishedReg": "2018-08-07", 
    "description": "FLAMSA followed by sequential reduced intensity conditioning and treosulfan/fludarabine are frequently used conditioning approaches used in centers of the European Society for Blood and Marrow Transplantation (EBMT) for older patients with acute myeloid leukemia (AML). It is currently unknown whether any of these regimens is superior to the others in terms of disease control and toxicity. Using the Acute Leukemia Working Party/EBMT multicenter registry we compared the outcomes of AML patients 45\u201365 of age transplanted between the years 2007 and 2016. A total of 629 patients were included in the analysis: 281 in the Treo/Flu group, 203 in the FLAMSA/TBI group, and 145 in the FLAMSA/Busulfan group. In multivariate analysis, FLAMSA/TBI conditioned patients had a decreased risk of relapse (hazard ratio (HR)\u2009=\u20090.43; 95% confidence interval (CI), 0.25\u20130.75; p\u2009=\u20090.002) and superior leukemia-free survival (HR\u2009=\u20090.67; 95% CI, 0.45\u20130.98; p\u2009=\u20090.042) compared to Treo/Flu conditioned patients. Rates of acute graft-versus-host disease (GVHD) were significantly higher in the FLAMSA/TBI group compared to the Treo/Flu group (HR\u2009=\u20092.004; 95% CI, 1.09\u20133.67; p\u2009=\u20090.024). Overall survival, non-relapse mortality, and chronic GVHD were not significantly impacted by the specific regimen used. The choice of either FLAMSA/TBI, FLAMSA/Bu, or Treo/Flu results in no major impact on survival of older AML patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41409-018-0288-0", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "54"
      }
    ], 
    "keywords": [
      "acute myeloid leukemia", 
      "reduced intensity conditioning", 
      "Flu group", 
      "intensity conditioning", 
      "myeloid leukemia", 
      "TBI group", 
      "superior leukemia-free survival", 
      "non-relapse mortality", 
      "older AML patients", 
      "leukemia-free survival", 
      "busulfan group", 
      "acute graft", 
      "chronic GVHD", 
      "fludarabine conditioning", 
      "multicenter registry", 
      "host disease", 
      "older patients", 
      "patients 45", 
      "overall survival", 
      "marrow transplantation", 
      "AML patients", 
      "decreased risk", 
      "specific regimen", 
      "patients", 
      "multivariate analysis", 
      "disease control", 
      "European Society", 
      "FLAMSA", 
      "survival", 
      "TBI", 
      "leukemia", 
      "group", 
      "GVHD", 
      "regimens", 
      "regimen", 
      "fludarabine", 
      "relapse", 
      "transplantation", 
      "registry", 
      "graft", 
      "mortality", 
      "disease", 
      "blood", 
      "years 2007", 
      "flu", 
      "outcomes", 
      "age", 
      "conditioning", 
      "total", 
      "major impact", 
      "risk", 
      "toxicity", 
      "conditioning approach", 
      "control", 
      "center", 
      "analysis", 
      "rate", 
      "impact", 
      "comparison", 
      "choice", 
      "Bu", 
      "results", 
      "society", 
      "approach", 
      "terms"
    ], 
    "name": "Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysis", 
    "pagination": "531-539", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1106016784"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41409-018-0288-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30087463"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41409-018-0288-0", 
      "https://app.dimensions.ai/details/publication/pub.1106016784"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T21:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_788.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41409-018-0288-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41409-018-0288-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41409-018-0288-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41409-018-0288-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41409-018-0288-0'


 

This table displays all metadata directly associated to this object as RDF triples.

309 TRIPLES      21 PREDICATES      108 URIs      93 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41409-018-0288-0 schema:about N11cd4f4c16444c37be1be228dbee4828
2 N127a2a333d3441ca831ba94a93fdc6ea
3 N3d78a8db1e3a45d784a4bb635223b174
4 N75d2e43a007040f0acfe1b6fd9178e8d
5 N873ff42c5a7b43e094b3462ec4b7635e
6 N97731b821eea42aca615a48316ff018c
7 N989b327a1a4943ef83208c317786a0b8
8 N99c3a9af9fc24c50989a9b56eac2cd64
9 Nadc3d67688a442639b6142fa0337d401
10 Naf2c95348d0042e58d052bcbae9de00e
11 Nb9ed2e56ab704f5d8c4afda9b63e3111
12 anzsrc-for:11
13 anzsrc-for:1102
14 schema:author N0161e9d78aad4081b5ac5ee4df8e1a4a
15 schema:citation sg:pub.10.1007/s00277-016-2887-4
16 sg:pub.10.1038/bmt.2011.242
17 sg:pub.10.1038/bmt.2012.4
18 sg:pub.10.1038/bmt.2015.305
19 sg:pub.10.1038/sj.bmt.1701899
20 sg:pub.10.1038/sj.bmt.1705259
21 sg:pub.10.1038/sj.leu.2404037
22 schema:datePublished 2018-08-07
23 schema:datePublishedReg 2018-08-07
24 schema:description FLAMSA followed by sequential reduced intensity conditioning and treosulfan/fludarabine are frequently used conditioning approaches used in centers of the European Society for Blood and Marrow Transplantation (EBMT) for older patients with acute myeloid leukemia (AML). It is currently unknown whether any of these regimens is superior to the others in terms of disease control and toxicity. Using the Acute Leukemia Working Party/EBMT multicenter registry we compared the outcomes of AML patients 45–65 of age transplanted between the years 2007 and 2016. A total of 629 patients were included in the analysis: 281 in the Treo/Flu group, 203 in the FLAMSA/TBI group, and 145 in the FLAMSA/Busulfan group. In multivariate analysis, FLAMSA/TBI conditioned patients had a decreased risk of relapse (hazard ratio (HR) = 0.43; 95% confidence interval (CI), 0.25–0.75; p = 0.002) and superior leukemia-free survival (HR = 0.67; 95% CI, 0.45–0.98; p = 0.042) compared to Treo/Flu conditioned patients. Rates of acute graft-versus-host disease (GVHD) were significantly higher in the FLAMSA/TBI group compared to the Treo/Flu group (HR = 2.004; 95% CI, 1.09–3.67; p = 0.024). Overall survival, non-relapse mortality, and chronic GVHD were not significantly impacted by the specific regimen used. The choice of either FLAMSA/TBI, FLAMSA/Bu, or Treo/Flu results in no major impact on survival of older AML patients.
25 schema:genre article
26 schema:isAccessibleForFree false
27 schema:isPartOf N6c0bee8994be4fa8b4a809c219118222
28 N89065231a2ab488991bd6478a55ef59c
29 sg:journal.1096890
30 schema:keywords AML patients
31 Bu
32 European Society
33 FLAMSA
34 Flu group
35 GVHD
36 TBI
37 TBI group
38 acute graft
39 acute myeloid leukemia
40 age
41 analysis
42 approach
43 blood
44 busulfan group
45 center
46 choice
47 chronic GVHD
48 comparison
49 conditioning
50 conditioning approach
51 control
52 decreased risk
53 disease
54 disease control
55 flu
56 fludarabine
57 fludarabine conditioning
58 graft
59 group
60 host disease
61 impact
62 intensity conditioning
63 leukemia
64 leukemia-free survival
65 major impact
66 marrow transplantation
67 mortality
68 multicenter registry
69 multivariate analysis
70 myeloid leukemia
71 non-relapse mortality
72 older AML patients
73 older patients
74 outcomes
75 overall survival
76 patients
77 patients 45
78 rate
79 reduced intensity conditioning
80 regimen
81 regimens
82 registry
83 relapse
84 results
85 risk
86 society
87 specific regimen
88 superior leukemia-free survival
89 survival
90 terms
91 total
92 toxicity
93 transplantation
94 years 2007
95 schema:name Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysis
96 schema:pagination 531-539
97 schema:productId N05080bb86d434c21bfefe8e6fc302785
98 N4fa8f6feacfd442d898ba25136970d51
99 Ndfdc1a83994f4cbb853dc039651f7659
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106016784
101 https://doi.org/10.1038/s41409-018-0288-0
102 schema:sdDatePublished 2022-11-24T21:04
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher N44d79c38b547496bba9527c522ed15ae
105 schema:url https://doi.org/10.1038/s41409-018-0288-0
106 sgo:license sg:explorer/license/
107 sgo:sdDataset articles
108 rdf:type schema:ScholarlyArticle
109 N013e875cabb04735a244dc995ec1ad15 rdf:first sg:person.01315375311.24
110 rdf:rest Nba5b7cb146114c718d39d353ca089194
111 N0161e9d78aad4081b5ac5ee4df8e1a4a rdf:first sg:person.012411736330.29
112 rdf:rest N7584750185f6434085ccb243184c3405
113 N03591a7bbf3e4d0fb7ba140bb3a7bf3d rdf:first sg:person.01045667334.08
114 rdf:rest N64f5fab50acf44b2be9e4d2ca3a9b0cd
115 N05080bb86d434c21bfefe8e6fc302785 schema:name doi
116 schema:value 10.1038/s41409-018-0288-0
117 rdf:type schema:PropertyValue
118 N11cd4f4c16444c37be1be228dbee4828 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Busulfan
120 rdf:type schema:DefinedTerm
121 N127a2a333d3441ca831ba94a93fdc6ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Female
123 rdf:type schema:DefinedTerm
124 N3d78a8db1e3a45d784a4bb635223b174 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Vidarabine
126 rdf:type schema:DefinedTerm
127 N44d79c38b547496bba9527c522ed15ae schema:name Springer Nature - SN SciGraph project
128 rdf:type schema:Organization
129 N4fa8f6feacfd442d898ba25136970d51 schema:name pubmed_id
130 schema:value 30087463
131 rdf:type schema:PropertyValue
132 N64f5fab50acf44b2be9e4d2ca3a9b0cd rdf:first sg:person.01246454160.01
133 rdf:rest N8216e67f2f4140928889a433cfac8694
134 N6c0bee8994be4fa8b4a809c219118222 schema:volumeNumber 54
135 rdf:type schema:PublicationVolume
136 N70185c21cd5c4fdcbfca3f3c9f2c1668 rdf:first sg:person.010617354074.64
137 rdf:rest N8f95aa1b05884cf6a3f1af3480c6564f
138 N74e9934ed8fa4b59afcfc387e1ab52d3 rdf:first sg:person.01270754501.00
139 rdf:rest N013e875cabb04735a244dc995ec1ad15
140 N7584750185f6434085ccb243184c3405 rdf:first sg:person.0762572112.39
141 rdf:rest N9918414ef2f54645abac3b01db84a314
142 N75d2e43a007040f0acfe1b6fd9178e8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Leukemia, Myeloid, Acute
144 rdf:type schema:DefinedTerm
145 N8216e67f2f4140928889a433cfac8694 rdf:first sg:person.01221434470.33
146 rdf:rest N74e9934ed8fa4b59afcfc387e1ab52d3
147 N873ff42c5a7b43e094b3462ec4b7635e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Male
149 rdf:type schema:DefinedTerm
150 N89065231a2ab488991bd6478a55ef59c schema:issueNumber 4
151 rdf:type schema:PublicationIssue
152 N8f95aa1b05884cf6a3f1af3480c6564f rdf:first sg:person.01225227464.09
153 rdf:rest N03591a7bbf3e4d0fb7ba140bb3a7bf3d
154 N97731b821eea42aca615a48316ff018c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Aged
156 rdf:type schema:DefinedTerm
157 N989b327a1a4943ef83208c317786a0b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Hematopoietic Stem Cell Transplantation
159 rdf:type schema:DefinedTerm
160 N9918414ef2f54645abac3b01db84a314 rdf:first sg:person.07616054555.72
161 rdf:rest Nef2b5a8fa4874fa78e6825300028c243
162 N99c3a9af9fc24c50989a9b56eac2cd64 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Middle Aged
164 rdf:type schema:DefinedTerm
165 Nadc3d67688a442639b6142fa0337d401 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Transplantation Conditioning
167 rdf:type schema:DefinedTerm
168 Naf2c95348d0042e58d052bcbae9de00e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Survival Rate
170 rdf:type schema:DefinedTerm
171 Nb9ed2e56ab704f5d8c4afda9b63e3111 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Humans
173 rdf:type schema:DefinedTerm
174 Nba5b7cb146114c718d39d353ca089194 rdf:first sg:person.0644135047.33
175 rdf:rest Nca2a878f2685439fa4c293195d0563dc
176 Nca2a878f2685439fa4c293195d0563dc rdf:first sg:person.0644252102.00
177 rdf:rest rdf:nil
178 Ndfdc1a83994f4cbb853dc039651f7659 schema:name dimensions_id
179 schema:value pub.1106016784
180 rdf:type schema:PropertyValue
181 Nef2b5a8fa4874fa78e6825300028c243 rdf:first sg:person.07531174677.79
182 rdf:rest N70185c21cd5c4fdcbfca3f3c9f2c1668
183 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
184 schema:name Medical and Health Sciences
185 rdf:type schema:DefinedTerm
186 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
187 schema:name Cardiorespiratory Medicine and Haematology
188 rdf:type schema:DefinedTerm
189 sg:journal.1096890 schema:issn 0268-3369
190 1476-5365
191 schema:name Bone Marrow Transplantation
192 schema:publisher Springer Nature
193 rdf:type schema:Periodical
194 sg:person.01045667334.08 schema:affiliation grid-institutes:grid.412554.3
195 schema:familyName Mayer
196 schema:givenName Jiri
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045667334.08
198 rdf:type schema:Person
199 sg:person.010617354074.64 schema:affiliation grid-institutes:None
200 schema:familyName Brecht
201 schema:givenName Arne
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010617354074.64
203 rdf:type schema:Person
204 sg:person.01221434470.33 schema:affiliation grid-institutes:grid.411937.9
205 schema:familyName Bittenbring
206 schema:givenName Jörg
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221434470.33
208 rdf:type schema:Person
209 sg:person.01225227464.09 schema:affiliation grid-institutes:grid.10423.34
210 schema:familyName Ganser
211 schema:givenName Arnold
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225227464.09
213 rdf:type schema:Person
214 sg:person.012411736330.29 schema:affiliation grid-institutes:grid.46699.34
215 schema:familyName Sheth
216 schema:givenName Vipul
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012411736330.29
218 rdf:type schema:Person
219 sg:person.01246454160.01 schema:affiliation grid-institutes:None
220 schema:familyName Labussière-Wallet
221 schema:givenName Hélène
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246454160.01
223 rdf:type schema:Person
224 sg:person.01270754501.00 schema:affiliation grid-institutes:grid.12136.37
225 schema:familyName Shouval
226 schema:givenName Roni
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270754501.00
228 rdf:type schema:Person
229 sg:person.01315375311.24 schema:affiliation grid-institutes:grid.152326.1
230 schema:familyName Savani
231 schema:givenName Bipin
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315375311.24
233 rdf:type schema:Person
234 sg:person.0644135047.33 schema:affiliation grid-institutes:grid.412370.3
235 schema:familyName Mohty
236 schema:givenName Mohammad
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644135047.33
238 rdf:type schema:Person
239 sg:person.0644252102.00 schema:affiliation grid-institutes:grid.12136.37
240 schema:familyName Nagler
241 schema:givenName Arnon
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644252102.00
243 rdf:type schema:Person
244 sg:person.07531174677.79 schema:affiliation grid-institutes:grid.15485.3d
245 schema:familyName Volin
246 schema:givenName Liisa
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07531174677.79
248 rdf:type schema:Person
249 sg:person.07616054555.72 schema:affiliation grid-institutes:grid.12136.37
250 schema:familyName Canaani
251 schema:givenName Jonathan
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07616054555.72
253 rdf:type schema:Person
254 sg:person.0762572112.39 schema:affiliation grid-institutes:grid.412370.3
255 schema:familyName Labopin
256 schema:givenName Myriam
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762572112.39
258 rdf:type schema:Person
259 sg:pub.10.1007/s00277-016-2887-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007456209
260 https://doi.org/10.1007/s00277-016-2887-4
261 rdf:type schema:CreativeWork
262 sg:pub.10.1038/bmt.2011.242 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023661469
263 https://doi.org/10.1038/bmt.2011.242
264 rdf:type schema:CreativeWork
265 sg:pub.10.1038/bmt.2012.4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037876400
266 https://doi.org/10.1038/bmt.2012.4
267 rdf:type schema:CreativeWork
268 sg:pub.10.1038/bmt.2015.305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022710270
269 https://doi.org/10.1038/bmt.2015.305
270 rdf:type schema:CreativeWork
271 sg:pub.10.1038/sj.bmt.1701899 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053658735
272 https://doi.org/10.1038/sj.bmt.1701899
273 rdf:type schema:CreativeWork
274 sg:pub.10.1038/sj.bmt.1705259 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013673798
275 https://doi.org/10.1038/sj.bmt.1705259
276 rdf:type schema:CreativeWork
277 sg:pub.10.1038/sj.leu.2404037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042454383
278 https://doi.org/10.1038/sj.leu.2404037
279 rdf:type schema:CreativeWork
280 grid-institutes:None schema:alternateName Center Hospitalier Lyon Sud, Pavillon Marcel Bérard -Bat 1G, Service Hematologie, Lyon, France
281 Deutsche Klinik fuer diagnostik, KMT Zentrum, Weisbaden, Germany
282 schema:name Center Hospitalier Lyon Sud, Pavillon Marcel Bérard -Bat 1G, Service Hematologie, Lyon, France
283 Deutsche Klinik fuer diagnostik, KMT Zentrum, Weisbaden, Germany
284 rdf:type schema:Organization
285 grid-institutes:grid.10423.34 schema:alternateName Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
286 schema:name Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
287 rdf:type schema:Organization
288 grid-institutes:grid.12136.37 schema:alternateName Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel
289 schema:name EBMT Paris Office, CEREST-TC, Department of Hematology, Saint Antoine Hospital, Paris, France
290 Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel
291 rdf:type schema:Organization
292 grid-institutes:grid.152326.1 schema:alternateName Department of Hematology and Stem Cell Transplant, Vanderbilt University, Nashville, TN, USA
293 schema:name Department of Hematology and Stem Cell Transplant, Vanderbilt University, Nashville, TN, USA
294 rdf:type schema:Organization
295 grid-institutes:grid.15485.3d schema:alternateName Stem Cell Transplantation Unit, HUCH Comprehensive Cancer Center, Helsinki, Finland
296 schema:name Stem Cell Transplantation Unit, HUCH Comprehensive Cancer Center, Helsinki, Finland
297 rdf:type schema:Organization
298 grid-institutes:grid.411937.9 schema:alternateName Department of Internal Medicine, BMT Unit, University of Saarland University Hospital, Homburg, Germany
299 schema:name Department of Internal Medicine, BMT Unit, University of Saarland University Hospital, Homburg, Germany
300 rdf:type schema:Organization
301 grid-institutes:grid.412370.3 schema:alternateName EBMT Paris Office, CEREST-TC, Department of Hematology, Saint Antoine Hospital, Paris, France
302 schema:name EBMT Paris Office, CEREST-TC, Department of Hematology, Saint Antoine Hospital, Paris, France
303 rdf:type schema:Organization
304 grid-institutes:grid.412554.3 schema:alternateName Department of Internal Medicine, Hematooncology, University Hospital Brno, Brno, Czech Republic
305 schema:name Department of Internal Medicine, Hematooncology, University Hospital Brno, Brno, Czech Republic
306 rdf:type schema:Organization
307 grid-institutes:grid.46699.34 schema:alternateName Department of Hematology and Stem Cell Transplant, Kings College Hospital, London, London, UK
308 schema:name Department of Hematology and Stem Cell Transplant, Kings College Hospital, London, London, UK
309 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...